30 results
8-K
EX-99.1
ETON
Eton Pharmaceuticals Inc
9 May 24
Eton Pharmaceuticals Reports First Quarter 2024 Financial Results
4:17pm
patient additions. The launches of Betaine and Nitisinone have further strengthened Eton’s relationships with the metabolic community and have helped
8-K
EX-99.1
ETON
Eton Pharmaceuticals Inc
22 Mar 24
Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE® for Phenylketonuria
6:55am
U.S. PKU medical formula market. With our sales force and existing relationships in the metabolic community, we believe we can significantly increase
8-K
EX-99.1
ETON
Eton Pharmaceuticals Inc
11 May 23
Eton Pharmaceuticals Reports First Quarter 2023 Financial Results
4:15pm
campaign and implemented initiatives to further increase its engagement with the adrenal insufficiency community.
Launch of Betaine Anhydrous
8-K
EX-99.1
u8zukfe
15 Nov 21
Eton Pharmaceuticals Reports Third Quarter Financial Results
12:00am
8-K
EX-99.1
5400uz
16 Aug 21
Eton Pharmaceuticals Reports Second Quarter Financial Results
4:33pm
8-K
EX-99.1
3twtfoex
15 Jun 21
Eton Pharmaceuticals Acquires U.S. and Canadian Rights to ZENEO® Hydrocortisone Autoinjector
5:24pm
8-K
EX-99.1
c434l5p1 v4cvq
13 May 21
Eton Pharmaceuticals Reports Record Revenue and Earnings
4:43pm
424B3
biguo1b18lhxeu
9 Apr 21
Prospectus supplement
7:00am
424B3
fdishwymk
7 Apr 21
Prospectus supplement
4:06pm
8-K
EX-99.1
3qha8
22 Oct 19
Eton Pharmaceuticals Announces U.S. FDA Approval of Biorphen® (phenylephrine HCI) Injection
7:33am